The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …

Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator)(Netherlands),
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …

Abstract The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines
program was developed to aid clinicians in the management of these complex patients, as …

Cardiac amyloidosis (CA) is a rare but potentially life-threatening disease in which misfolded
proteins accumulate in the cardiac wall tissue. Heart rhythm disorders in CA, including …

Las guías de práctica clínica (GPC) tienen como objetivo reunir y evaluar toda la evidencia
relevante disponible durante el proceso de elaboración sobre un tema particular para …

Cardiac Amyloidosis is an infiltrative cardiomyopathy which occurs secondary to deposition
of mis-folded protein in the myocardium, with the two most common subtypes being AL …

Cardiac amyloidosis (CA) is an infiltrative cardiomyopathy characterized by extracellular
deposition of mis-folded proteins called amyloid. Cardiac complications of CA are several …

Cardiac involvement in amyloidosis is associated with a poor prognosis. Data on the burden
of arrhythmias in patients with cardiac amyloidosis (CA) during hospitalization are lacking …

Transthyretin amyloidosis cardiomyopathy (ATTR-CM) is commonly diagnosed in older
adults, in particular the wild-type (ATTRwt), which is regarded as an age-related disease …

Introduction and objectives Transthyretin cardiac amyloidosis (ATTR-CA) patients often have
atrial fibrillation and increased bleeding/thrombogenic risks. We aimed to evaluate …